1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Distribution, frequency, and dose of intra-arterial verapamil infusion
Vessel Segment Frequency (n = 720) Median Dose (mg) (range) ICA 536 10.0 (2.0–30.0) Vertebral artery 144 8.1 (2.0–20.0) A1 ACA 26 7.5 (5.0–30.0) CCA 8 15.0 (5.0–15.0) M1 MCA 4 10.0 (10.0–10.0) A2 ACA 1 10 Proatlantal artery 1 5